Delivery Order SPE2DB22D1106-SPE2DB24FDWP7
Award Date
1/23/24
Potential Completion Date
1/24/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,562,868,973 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $94,212.97 and a period of performance through November 21, 2023. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract supports the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4,564,534,508 units of Bupropion HCL XL 150 mg Tablets in 500-count bottles. The contract, valued at $19,118.32, has a firm fixed price and a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FDSN5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,210.62 firm-fixed-price delivery order is for 4,563,189,541 units of Bupropion HCL XL 150 mg Tablets, to be delivered by December 28, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,783,919 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract has a firm fixed price of $22,368.57 and a period of performance through February 28, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
The federal contract award is for the delivery of pharmaceutical products, including Bupropion XL 300mg 500s, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $12,094.17 and a completion date of April 23, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,854.28, is for the delivery of Bupropion HCL XL 300 mg tablets over the period ending on January 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
This federal contract award, valued at $1,075.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,422,769 units of Bupropion HCL XL 300 mg tablets. This is a Firm Fixed Price Delivery Order contract with a completion date of July 7, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
The federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZYJ, is for the delivery of 4,563,586,968 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order with a ceiling value of $23,937.54. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $51,618.39, is for the delivery of 4,564,448,914 units of Bupropion HCL XL 150 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of May 1, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $25,866.44, is for the delivery of Bupropion HCL XL 150 mg tablets over a 2-year period ending in May 2024. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation mentioned, indicating an open competition. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) that...